Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial protocol

BACKGROUND: Various methods are currently used for the induction of labor. Nevertheless, the most effective method with the fewest side effects remains to be established. Misoprostol, administered vaginally, has been routinely used for this purpose; however, other forms of administration are being p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Reprod Health
Päätekijät: Gattás, Daniele Sofia Moraes Barros, da Silva Junior, José Roberto, Souza, Alex Sandro Rolland, Feitosa, Francisco Edson, de Amorim, Melania Maria Ramos
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5907413/
https://ncbi.nlm.nih.gov/pubmed/29669596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12978-018-0508-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia